Prognostic Applications Are Growing Rapidly for Cancer Biomarkers

The number of publications that describe novel biomarkers for cancer has grown by an average of 24% over the last 5 years. As previously reported, this growth rate is essentially the same as for novel biomarkers across all diseases.

The Personalized Medicine Coalition Has Issued Its Fourth State of the Industry Report

The Personalized Medicine Coalition last month released their fourth annual report describing the state of the industry for personalized medicine. While it is primarily an overview piece that is written for policy makers in government and reimbursement-related roles, it is certainly worth reading ...

There Has Been a Surge in New Biomarkers During 2014

There has been a significant surge in the number of new biomarkers described in the literature during 2014.

Draft Guidance for LDTs Has Finally Been Released

In response to congressional pressure, FDA has released a copy of its long-awaited draft guidance covering regulation of LDTs. FDA seems to have addressed many if not all of the concerns regarding negative impacts from LDT regulation, at least in writing the guidance. Actual implementation will be ...




Pharmacovigilance and Safety Biomarkers

New Call-to-action

Subscribe for Updates

Download our Free IVD Trends Report